Skip to main content
. 2017 May 31;8:625. doi: 10.3389/fimmu.2017.00625

Figure 1.

Figure 1

Antigenic profile of cutaneous melanoma (CM) cell lines that compose the CSF-470 vaccine as determined by RNAseq (A). Expression of GD2 and GD3 gangliosides in CSF-470 vaccine as determined by flow cytometry (B); isotype-matched immunoglobulins were used as controls to set unspecific labeling.